Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease

Table 5

Comparison of AUROC curve values among noninvasive markers for predicting IFG.

	AUROC	95% confidence interval	Standard error	P value
All
FLI	0.689	0.004	0.682–0.697	<0.001
LAP	0.675	0.004	0.667–0.683	<0.001
With fatty liver
FLI	0.609	0.006	0.598–0.62	<0.001
LAP	0.602	0.006	0.591–0.613	<0.001
Without fatty liver
FLI	0.669	0.006	0.656–0.681	<0.001
LAP	0.643	0.007	0.629–0.656	<0.001
BMI (lean and normal)
FLI	0.673	0.008	0.658–0.688	<0.001
LAP	0.642	0.008	0.626–0.659	<0.001
BMI (overweight and obesity)
FLI	0.616	0.005	0.606–0.627	<0.001
LAP	0.605	0.005	0.595–0.615	<0.001

IFG, impaired fasting glucose; AUROC, area under the receiver operating characteristic; FLI, fatty liver index; LAP, lipid accumulation product; BMI, body mass index.